Ehud Ivri is the CTO and co-founder of Kedalion Therapeutics. Prior to this, they were a consultant to BioDot on piezoelectric dispensing and other piezoelectric applications. Before that, they were the CTO of Nektar Therapeutics from June 2005 to November 2009. Ehud also founded Aerogen in May 1995 and served as its CTO until July 2005.
Ehud Ivri works with Mark Murray - CFO, Joseph Gilbert - Director, Clinical Operations, and Reynaldo Quintana - SVP, Research & Development. Their manager is Mark Blumenkranz, Chairman, CEO & Co-Founder.
Current role